Clin2
NCT06853340Possibly a fitRecruiting

Calcium and blood vessel hardening in sepsis shock

Septic ShockCalcium Sensing ReceptorCalcium Phosphate DisordersInflammationMonocyte

Treatments studied

Part of Infections clinical trials.

This study looks at how calcium buildup in blood vessels and a specific receptor on immune cells might affect recovery from septic shock. It aims to understand if these factors impact how well patients respond to treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
66 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are in the intensive care unit with septic shock and started blood pressure medicine within the last 24 hours
  • You have a lactate level higher than 2 mmol/L
  • You live in France year-round
  • You have French social security coverage
  • You have not taken part in another drug study in the past 30 days

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05586282Recruiting
Study proteins that may worsen fluid leaks in shock

This trial studies specific body proteins to understand why fluid can leak from blood vessels during dangerous shock after infection or heart problems. If you (or your representative) qualify, your team will collect information and possibly samples to see whether these proteins relate to recovery and treatment response.

Paris
NCT07203833Recruiting
Vasorin test for shock diagnosis and outlook

This study looks at a protein called vasorin in the blood to see if it can help diagnose and predict outcomes in people with severe shock in the ICU. It compares patients with septic shock (caused by infection) to those with shock from other causes.

Amiens
NCT07711197Not yet recruiting
Blood filtering treatment for septic shock and blood vessel health

This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.

Budapest
NCT04067674Recruiting
Study immune changes in adults with septic shock

This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.

Lyon
NCT07721974Not yet recruiting
Studying blood pressure hormones in septic shock

This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.

NCT07442032Not yet recruiting
Heart and blood vessel patterns in sepsis patients

This study looks at how sepsis affects your heart and blood vessels. You may be eligible if you have a serious infection that is not responding to fluids and you need medicine to keep your blood pressure up.

Hear when a new Septic Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.